NACDS is applauding today the introduction of bipartisan legislation in the U.S. Senate (S. 2477 - the Equitable Community Access to Pharmacist Services Act) that would help maintain the post-pandemic pharmacy access that Americans rely on and expect.
NACDS looks forward to continuing work with leaders in the U.S. Congress to address the “pharmaceutical benefit manipulation” that harms the most vulnerable in the Medicaid and Medicare programs.
More Than 190 Organizations Support S. 2447 to Provide Payment for Pharmacist Services for COVID-19, Flu, Strep, and RSV Under Medicare Part B.
A newly released NACDS video urges this message ahead of a July 26 legislative markup scheduled by the U.S. Senate Committee on Finance.
“S. 1038 and S. 2052 are vital for real PBM reform, and for addressing ‘pharmaceutical benefit manipulation’ that harms the most vulnerable in the Medicaid and Medicare programs.”
From industry trade press, to publications serving the broader business community, to media outlets relied on by government decision-makers, important story lines about pharmacy benefit manager reform continue to generate headlines and attention across the nation.
NACDS today praised the bipartisan introduction of the Protect Patient Access to Pharmacies Act (S. 2052) – a bill that would help preserve Medicare beneficiaries’ access to their pharmacy of choice and help stop “pharmaceutical benefit manipulation” that harms patients and pharmacies alike.
Organizations representing pharmacists and pharmacies are applauding the Protect Patient Access to Pharmacies Act (S. 2052) introduced on June 21 in the U.S. Senate.
Action is essential component of PBM reform in the Medicaid program and vital for patients and the pharmacies serving them.
Organizations commend House Committee on Oversight and Accountability for hearing on PBM tactics.
